Upregulation of major histocompatibility complex class II antigens in hepatocytes in Doberman hepatitis

Veterinary Immunology and Immunopathology

Volumn 96, Issue 1-2, 2003, Pages 1-12

  Speeti, M ^a   Stahls A ^b   Meri, S ^b   Westermarck, E ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Autoimmunity; Chronic hepatitis; Copper; Doberman; Dog; Liver

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DOG DISEASE; HEPATITIS; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; LIVER FAILURE; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; NONHUMAN; UPREGULATION;

CANIS FAMILIARIS;

EID: 0141651837     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(03)00134-X     Document Type: Article

References (31)

1. Ballardini G., Mirakian R., Bianchi F.B., Doniach D., Mirakian R., Pisi E., Bottazzo G.F. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet. 3:1984;1009-1013.
2. Baum H., Staines N.A. MHC-derived peptides and the CD4+ T-cell repertoire: implications for autoimmune disease. Cytocines, Cell. Molec. Therapy. 3:1997;115-125.
3. Boisclair J., Dore M., Beauchamp G., Chouinard L., Girard C. Characterization of the inflammatory infiltrate in canine chronic hepatitis. Vet. Pathol. 38:2001;628-635.
4. Broome U., Glaumann H., Hultcrantz R., Forsum U. Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis. Scand. J. Gastroenterol. 25:1990;54-58.
5. Cornelius L.M. Chronic weight loss. The case of a Doberman pinscher. Vet. Med. Rep. 1:1989;351-357.
6. Crawford M.A., Schall W.D., Jensen R.K., Tasker J.B. Chronic active hepatitis in 26 Doberman Pinschers. JAVMA. 187:1985;1343-1349.
7. Day M.J. Expression of major histocompatibility complex class II molecules by dermal inflammatory cells, epidermal Langerhans cells and keratinocytes in canine dermatological disease. J. Comp. Path. 115:1996;315-326.
8. Doveren R.F.C., Buurman W.A., Schutte B., Groenewegen G., van der Linden C.J. Class II antigens on canine T lymphocytes. Tissue Antigens. 25:1985;255-256.
9. Floreani A., Bennett M.K., McLachlan H.C., Bassendine M.F., James O.F. Progression of autoimmune damage in primary biliary cirrhosis: an immunohistochemical study. Autoimmunity. 2(4):1989;311-321.
10. Germain R.N., Hendrix L.R. MHC class II structure, occupancy and surface expression determinated by post-endoplasmic reticulum antigen binding. Nature. 353:1991;134-139.
11. German A.J., Bland P.W., Hall E.J., Day M.J. Expression of major histocompatibility complex class II antigens in canine intestine. Vet. Immunol. Immunopathol. 61:1998;171-180.
12. Hamilton F., Black M., Farquharson M.A., Stewart C., Foulis A.K. Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease. Clin. Exp. Immunol. 83:1991;64-68.
13. Johnson G.F., Zawie D.A., Gilbertson S.R., Sternlieb I. Chronic active hepatitis in Doberman Pinschers. JAVMA. 180:1982;1438-1442.
14. Ljunggren G., Andersson D.J. Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells. J. Reprod. Immunol. 38:1998;123-138.
15. Mandigers, P., van den Ingh, T., Bode, P., Teske, E., Ubbink, G., Rothuizen, J., 2000. Incidence of subclinical hepatitis in three year old dobermans and associated liver copper values. In: Proceedings of the ESVIM Congress, pp. 58-59.
16. McDevitt H.O. The role MHC class II molecules in susceptibility and resistance to autoimmunity. Curr. Opin. Immunol. 10:1998;677-681.
17. Mellins E.D. The role of the MHC in autoimmunity: an overview. J. Rheumatol. 19:1992;63-69.
18. Meyer D.J., Iverson W.O., Terrell T.G. Obstructive jaundice associated with chronic active hepatitis in a dog. JAVMA. 176:1980;41-44.
19. Nepon G.T. MHC and autoimmune diseases. Immunol. Ser. 59:1993;143-164.
20. Rothuizen J. Current concepts of chronic hepatitis in dogs. Eur. J. Comparat. Gastroenterol. 2:1997;15-20.
21. Sevelius, E., Andersson, M., Jönsson, L., 1993. Chronic liver disease in the dog: new approaches. In: Proceedings of Waltham/ESCG Symposium on Focus on Gastroenterology, pp. 43-48.
22. Speeti M., Ihantola M., Westermarck E. Subclinical versus clinical hepatitis in the dobermann: evaluation of changes in blood parameters. J. Small Anim. Pract. 37:1996;465-470.
23. Speeti M., Eriksson J., Saari S., Westermarck E. Lesions of subclinical doberman hepatitis. Vet. Pathol. 35:1998;361-369.
24. Speeti M., Eriksson J., Westermarck E. Some new aspects of the role of copper in doberman hepatitis. Eur. J. Vet. Pathol. 5:1999;51-56.
25. Spengler U., Pape G.R., Hoffman R.M., Johnson J.P., Eisenburg J., Paumgartner G., Riethmuller G. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology. 8:1988;459-462.
26. Tafti M., Nishino S., Aldrich M.S., Liao W., Dement W.C., Mignot E., Neuroscience J. Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in a canine model. J. Neurosci. 16:1996;4588-4595.
27. Thornburg L.P. Histomorphological and immunohistochemical studies of chronic active hepatitis in Doberman Pinschers. Vet. Pathol. 35:1998;380-385.
28. Tizard, I.R., 1996. MHC: the antigen-presenting receptors. In: Tizard, I.R. (Ed.), Veterinary Immunology: An introduction. Saunders, Philadelphia, pp. 55-66.
29. van den Ingh T.S.G.A.M., Rothuizen J., Cupery R. Chronic active hepatitis with cirrhosis in the Doberman Pinscher. Vet. Quart. 10:1988;84-89.
30. Weetman A.P. New aspects of thyroid immunity. Horm. Res. 48:1997;51-54.
31. Weiss D.J., Armstrong P.J., Mruthyunjaya A. Anti-liver membrane protein antibodies in dogs with chronic hepatitis. J. Vet. Internal Med. 9:1995;267-271.